Tempest Therapeutics, Inc. TPST
Set alert
0.47 USD -0.02 -4.74%
At close
0.50 +0.03 +6.95%
Pre-market · Nov 3, 7:00 AM ET
0.4703 Day range 0.5049
0.47 52-week range 10.33
- YTD
- -83.55%
- 1 year
- -95.29%
- Open
- 0.50
- Prev close
- 0.4955
- Mkt cap
- 9.44M
- Vol
- 160.45K
- Avg vol
- 2.58M
- EPS
- -3.93
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.4703
- High
- 0.5049
- Forward P/E
- -0.61
- Beta
- -2.78
- Short ratio
- 0.39
- Inst. own
- 23.02%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.95482
- 200-d avg
- 2.12
- 1y target
- 18.75
3M chart
Signals (20)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 30, 2026 | 3 days ago |
| RSI: Oversold | Oct 21, 2026 | 1 week ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| RSI: Oversold | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 3, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
Financial health
Altman Z-Score
-53.69 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.5×
FY 2016 5y median -7.2× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.8×
FY 2016 5y median 1.8× FY 2025
P/FCF -0.4×
FY 2016 5y median -0.8× FY 2025
EV/EBITDA -0.5×
FY 2016 5y median -0.5× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -225.2%
FY 2016 5y median -130.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -393.9%
FY 2016 5y median -197.2% FY 2025
ROIC -179.5%
FY 2016 5y median -86.1% FY 2025
ROA -155.1%
FY 2016 5y median -77.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 36.8%
FY 2016 FY 2025
EPS (diluted) -322.0%
FY 2016 FY 2025
Free Cash Flow 19.8%
FY 2016 FY 2025
Financial Health
Current Ratio 2.5×
FY 2016 5y median 3.4× FY 2025
Quick Ratio 2.5×
FY 2016 5y median 3.4× FY 2025
Debt / Equity 1.2×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA -0.0×
FY 2016 5y median 0.4× FY 2025
Interest Coverage -128×
FY 2016 5y median -21.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
